CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
92 hedge funds and large institutions have $334M invested in CTI BioPharma Corp. (DE) Common Stock in 2022 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
33% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 18
22% more call options, than puts
Call options by funds: $3.15M | Put options by funds: $2.57M
Holders
92
Holding in Top 10
6
Calls
$3.15M
Puts
$2.57M
Top Buyers
| 1 | +$19.9M | |
| 2 | +$16.9M | |
| 3 | +$9.21M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$9.12M |
| 5 |
Two Sigma Investments
New York
|
+$6.84M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$8.8M | |
| 3 | -$5.55M | |
| 4 |
Renaissance Technologies
New York
|
-$1.14M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$942K |